SHARE

In last trading session, the stock price of EKSO BIONICS HOLDING (OTCBB:EKSO) declined more than 9% to close the trading session at $1.18. The decline came at a share volume of 1.17 million compared to monthly average share volume of 523,394.

The achievements

EKSO long-term goal is to make 1 million individuals stand and walk in its designed exoskeleton by February 2022. The first step towards achieving the defined objective is to focus on marketing medical exoskeletons to hospitals and rehabilitation centers in the U.S. and Europe.

The company commenced that task back in February 2012 with the sale of ‘Ekso’, an exoskeleton product targeting complete spinal cord injuries. Since then the company has extended its measures with the launch of Variable Assist software in July 2013 and release of next-generation Ekso GT in December 2013.

EKSO reported that its Variable Assist software allows people with lower extremity strength to use their own power for self-initiated walking. The Ekso GT gains on the experience of previous launches and incorporates the Variable Assist, enabling the company to expand marketing and sales measures beyond SCI-focused facilities to centers supporting stroke patients.

The problem factors

EKSO mentioned several factors in its annual report for the fiscal completed December 31, 2014, could impact future results. The expected cost, timing and progress of the commercialization and development of new services or products, and improvements to existing products can have an impact on the overall performance in the coming quarters.

The company’s ability to effectively sell and market the products and business expansion, both in terms of product diversification and unit sales will lead the earnings in the future. EKSO highlighted several other factors that can have a material impact on its performance including but not limited to, the regulatory approval to commercialize its medical devices, the broad customer adoption of services and products and competition.

EKSO

EKSO BIONICS HOLDING (OTCBB:EKSO) started the week with a major decline in the short term as it ended the trading session with a loss of      9.22%. The decline was aided by a volume of 1.1 million, much higher than the daily average of 368,000, indicating that some of the supply came from the disappointed investors. On the other hand, the retesting of the extreme short term channel lower boundary may push the price up, as seen on the chart attached. The real trend reversal can only be expected on a break above the long term trendline resistance.

LEAVE A REPLY